Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement

Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski

doi:10.1097/TP.0000000000001055

Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement

Transplantation. 2016 Feb;100 Suppl 2(Suppl 2):S1-44. doi: 10.1097/TP.0000000000001055.

Affiliation

¹ 1 Department of Surgery, University of Maryland School of Medicine, Baltimore MD. 2 Division of Transplantation, Massachusetts General Hospital, Boston MA. 3 Nuffield Department of Surgical Sciences and Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, United Kingdom. 4 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. 5 Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN. 6 Prodo Laboratories, LLC, Irvine, CA. 7 The Scharp-Lacy Research Institute, Irvine, CA. 8 Department of Medicine, St. Vincent's Hospital, St. Vincent's Institute of Medical Research and The University of Melbourne Victoria, Australia. 9 Division of Transplantation, Department of Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, WI. 10 Joslin Diabetes Center and Harvard Medical School, Boston, MA. 11 National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD. 12 Division of Transplantation, University of San Francisco Medical Center, San Francisco, CA. 13 Department of Surgery, Fukushima Medical University, Fukushima, Japan. 14 Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA. 15 Xenotransplantation Research Center, Department of Microbiology and Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. 16 The Center for Transplant and Renal Research, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, NSW, Australia. 17 Diabetes Research Institute, School of Medicine, University of Miami, Coral Gables, FL. 18 National Center for Global Health and Medicine, Tokyo, Japan. 19 Otsuka Pharmaceutical Factory inc, Naruto Japan. 20 Department of Medicine III, Technische Universität Dresden, Dresden, Germany. 21 Paul Langerhans Institute Dresden of Helmholtz Centre Munich at University Clinic Carl Gustav

No abstract available

Publication types

Consensus Development Conference
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Biomedical Research / trends*
Diabetes Mellitus / blood
Diabetes Mellitus / mortality
Diabetes Mellitus / surgery*
Diffusion of Innovation
Forecasting
Graft Rejection / immunology
Graft Rejection / prevention & control
Graft Survival
Heterografts
Humans
Hypoglycemic Agents / therapeutic use
Immunosuppressive Agents / therapeutic use
Insulin-Secreting Cells / immunology
Insulin-Secreting Cells / metabolism
Insulin-Secreting Cells / transplantation*
Islets of Langerhans Transplantation / adverse effects
Islets of Langerhans Transplantation / methods
Islets of Langerhans Transplantation / mortality
Islets of Langerhans Transplantation / trends*
Pancreas Transplantation / adverse effects
Pancreas Transplantation / methods
Pancreas Transplantation / mortality
Pancreas Transplantation / trends*
Phenotype
Regeneration
Regenerative Medicine / methods
Regenerative Medicine / trends*
Risk Factors
Stem Cell Transplantation / adverse effects
Stem Cell Transplantation / methods
Stem Cell Transplantation / mortality
Stem Cell Transplantation / trends*
Time Factors
Transplantation Tolerance
Treatment Outcome

Substances

Hypoglycemic Agents
Immunosuppressive Agents

Grants and funding

UC4 DK104207/DK/NIDDK NIH HHS/United States